Showing 1 - 20 results of 27 for search 'John Camm', query time: 0.06s
Refine Results
-
1
Virtual Symposium on Atrial Fibrillation in October 2005 by John Camm
Published 2005-07-01
Article -
2
Persistent Atrial Fibrillation: The Role of Left Atrial Posterior Wall Isolation and Ablation Strategies by Riyaz A. Kaba, Aziz Momin, John Camm
Published 2021-07-01
Article -
3
Managing thrombotic risk in patients with diabetes by A. John Camm, Hani Sabbour, Oliver Schnell, Francesco Summaria, Atul Verma
Published 2022-08-01
Article -
4
Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising... by Jörg Täubel, Georg Ferber, Ulrike Lorch, Duolao Wang, Mariano Sust, A John Camm
Published 2015-01-01
Article -
5
Risks and benefits of oral anticoagulants for stroke prophylaxis in atrial fibrillation according to body mass index: Nationwide cohort study of primary care records in EnglandRese... by Yoko M. Nakao, Kazuhiro Nakao, Jianhua Wu, Ramesh Nadarajah, A. John Camm, Chris P. Gale
Published 2022-12-01
Article -
6
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban by Paulus Kirchhof, Sylvia Haas, Pierre Amarenco, Susanne Hess, Marc Lambelet, Martin van Eickels, Alexander G. G. Turpie, A. John Camm
Published 2020-03-01
Article -
7
Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long‐Term Follow‐Up: Results From the NODE‐302 Study by James E. Ip, Benoit Coutu, Matthew T. Bennett, A. Shekhar Pandey, Bruce S. Stambler, Philip Sager, Michael Chen, Silvia Shardonofsky, Francis Plat, A. John Camm
Published 2023-10-01
Article -
8
-
9
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial by Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L. Meng, A. John Camm, Stefan H. Hohnloser, Anke Schulz, Melanie Wosnitza, Riccardo Cappato
Published 2020-01-01
Article -
10
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF by Giuseppe Ambrosio, A. John Camm, Jean‐Pierre Bassand, Ramon Corbalan, Gloria Kayani, Erberto Carluccio, Lorenzo G. Mantovani, Saverio Virdone, Ajay K. Kakkar, for the GARFIELD‐AF Investigators
Published 2021-04-01
Article -
11
Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study by Sarah Berlin, Andreas Goette, Luciana Summo, Janine Lossie, Alexander Gebauer, Naab Al-Saady, Leonardo Calo, Gerald Naccarelli, Wolf-Hagen Schunck, Robert Fischer, A.John Camm, Dobromir Dobrev
Published 2020-08-01
Article -
12
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) by Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Published 2019-04-01
Article -
13
Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases by Uğur Önsel Türk, Rezzan Deniz Acar, Taylan Akgün, Volkan Emren, Selçuk Kanat, Emir Karacağlar, Alper Kepez, Şeref Kul, Erdem Özel, Evrim Şimşek, Selcen Yakar Tülüce, Kamil Tülüce, A. John Camm
Published 2020-04-01
Article -
14
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry by Marita Knudsen Pope, Trygve S. Hall, Saverio Virdone, Dan Atar, A. John Camm, Karen S Pieper, Petr Jansky, Sylvia Haas, Shinya Goto, Elizaveta Panchenko, Gonzalo Baron-Esquivias, Pantep Angchaisuksiri, Ajay K Kakkar
Published 2023-12-01
Article -
15
Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke by Bernard J Gersh, Deborah M Siegal, Karen Pieper, Anne-Céline Martin, Keith A A Fox, Saverio Virdone, Shinya Goto, Alexander G G Turpie, Frederik H Verbrugge, John Camm, Pantep Angchaisuksiri
Published 2023-11-01
Article -
16
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry by Ajay K Kakkar, Keith A A Fox, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Karen S Pieper, Alexander G G Turpie, Gloria Kayani, Seil Oh, Jörn Nielsen, Frank Cools, John Camm, Marianne Brodmann, Patricia Apenteng, Antonio C P Barretto
Published 2023-02-01
Article -
17
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers by Kevin G. Pollock, Carissa Dickerson, Manjit Kainth, Sarah Lawton, Michael Hurst, Daniel M. Sugrue, Chris Arden, D. Wyn Davies, Anne-Céline Martin, Belinda Sandler, Jason Gordon, Usman Farooqui, David Clifton, Christian Mallen, Jennifer Rogers, Nathan R. Hill, A. John Camm, Alexander T. Cohen
Published 2024-01-01
Article -
18
2015 ESC GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND THE PREVENTION OF SUDDEN CARDIAC DEATH by Priori G. Silvia, Blomström-Lundqvist Carina, Andrea Mazzanti†, Nico Bloma, Martin Borggrefe, John Camm, Perry Mark Elliott, Donna Fitzsimons, Robert Hatala, Gerhard Hindricks, Paulus Kirchhof, Keld Kjeldsen, Karl-Heinz Kuck, Antonio Hernandez, Nikolaos Nikolaou, Tone M. Norekvål, Christian Spaulding, Dirk J. Van Veldhuisen
Published 2016-07-01
Article -
19
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry by Marita Knudsen Pope, Dan Atar, Arne Svilaas, Torstein Hole, Jørn Dalsgaard Nielsen, Ulrik Hintze, Milita Crisby, Pekka Raatikainen, K. E. Juhani Airaksinen, Saverio Virdone, Karen Pieper, Gloria Kayani, Jean-Yves Le Heuzey, Jan Steffel, Janina Stepinska, Jean-Pierre Bassand, A. John Camm
Published 2021-01-01
Article -
20
Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report by Gregory W. Albers, Richard A. Bernstein, Johannes Brachmann, John Camm, J. Donald Easton, Peter Fromm, Shinya Goto, Christopher B. Granger, Stefan H. Hohnloser, Elaine Hylek, Amir K. Jaffer, Derk W. Krieger, Rod Passman, Jesse M. Pines, Shelby D. Reed, Peter M. Rothwell, Peter R. Kowey
Published 2016-03-01
Article